Khosla Ventures

Khosla Ventures is a California-based venture capital firm founded in 2004 by Vinod Khosla. It provides capital and strategic guidance to startups across stages, focusing on technology-driven companies in areas such as artificial intelligence, climate and sustainability, enterprise software and services, fintech, digital health, medical technology and diagnostics, therapeutics, consumer products, and frontier technologies. The firm backs bold ventures with the potential to disrupt markets and improve lives, supporting companies from early to growth stages and working closely with entrepreneurs to apply science, technology and innovative business models. While primarily investing in North American technology companies, Khosla Ventures pursues opportunities globally and emphasizes experimentation and impact alongside financial returns. The firm also maintains related impact initiatives that support entrepreneurs addressing socio-economic challenges in emerging markets.

Alex Bentley

Partner and Investor

Ryno Blignaut

Operating Partner

Alice Brooks

Partner

Peter Buckland JD

COO, Partner, and Managing Director

Brian Byun

Venture Partner

Catherine Casuga

Operating Partner

Jon Chu

Partner

Adam Coates Ph.D

Operating Partner

Ardy Daie

Operating Partner

Bryan Gartner

Partner

Kanu Gulati

Partner

Kanupriya Gulati Ph.D

Partner and Investor

Judy Huang

Operating Partner

Jun Jeon

Principal

Samir Kaul

Founding General Partner

Vinod Khosla

Managing Director

Kelly Kinnard

Operating Partner

Alex Morgan

Partner

Nabeel Quryshi

Associate

Arash Rebek JD

Partner, Capital Formation

Jessy Rivest

Partner

Jai Sajnani

Partner

Leah Scanlan

Operating Partner

Nikita Shamgunov

Partner

Sven Strohband

Managing Director

Rajesh Swaminathan

Partner and Investor

Adina Tecklu

Partner

David Weiden

Partner

Reze Wong

Partner

Ece Erdagoz Wyrick

Principal

Past deals in Machine Learning

Cognition

Venture Round in 2025
Cognition AI is an applied AI lab focused on building end-to-end software agents that act as collaborative AI teammates. Their aim is to support engineering teams in being more efficient and innovative in their projects.

Danswer

Seed Round in 2025
Danswer is an AI-powered assistant that integrates with a company's tools and documents, facilitating swift retrieval of any required information.

Nomagic

Series B in 2025
Nomagic, Inc. is a technology company based in Warsaw, Poland, specializing in robotic manipulation solutions for order fulfillment in e-commerce. The company develops smart pick-and-place robotic systems that enhance efficiency, flexibility, and reliability in warehouses. By automating tedious tasks, Nomagic's solutions help reduce fulfillment costs and address labor shortages, allowing operations to scale effectively and operate around the clock. Powered by artificial intelligence, their robotic systems continuously learn and adapt to changing conditions, enabling warehouse operators to improve agility and ensure reliable delivery of goods. Nomagic's technology has been implemented in notable locations, including packing lines at Cdiscount, a leading French eCommerce platform.

Regie.ai

Series B in 2025
Regie.ai is a technology company that specializes in AI-powered sales engagement platforms. Its flagship product, RegieOne, automates outbound prospecting tasks, enhancing workflow efficiency for operations teams. The platform integrates sales engagement, parallel dialing, data enrichment, and intent data analysis, providing users with a centralized view of their processes. Additionally, Regie.ai offers an AI content platform that creates, tests, and analyzes personalized prospecting sales campaigns, aiming to boost engagement and optimize front-line performance.

Speak

Series C in 2024
Speak is an AI-powered language-learning mobile application designed to help users learn English through interactive conversation. The app utilizes advanced speech recognition techniques, allowing users to engage in dialogues about real-world scenarios. This approach enables individuals to improve their English speaking skills by identifying words and phrases, even when spoken with thick accents. Speak's focus on practical conversation enhances the learning experience, making it easier for users to communicate effectively in various contexts.

Moonvalley

Seed Round in 2024
Moonvalley builds creative studio, powered by the most capable video and image foundational models. The company is creating the place where generative image and video experiences will be built. Backed by Y-Combinator and Khosla Ventures.

Physical Intelligence

Series A in 2024
Physical Intelligence is a technology company specializing in integrating artificial intelligence with robotics and physical devices. It develops foundational models and learning algorithms to enable robots and other physical devices to perform a wide range of tasks across various industries.

Genie AI

Series A in 2024
Genie AI is a London-based legal tech company offering an AI-powered platform for drafting contracts. Its product SuperDrafter leverages the knowledge of a law firm to accelerate drafting, while Anonymiser redacts sensitive information. The platform understands contracts semantically and supports smart contract development. Genie AI also provides educational talks and practical training on smart contracts to improve risk management and efficiency. Founded in 2017, the company serves law firms seeking faster, more accurate contract workflows and exploration of smart contract adoption.

OpenAI

Venture Round in 2024
OpenAI is an AI research and deployment company that develops general-purpose artificial intelligence technologies and applies them to real-world problems. It conducts machine learning research and builds systems such as large-scale language models, multimodal input handling, and code generation to support automation, data analysis, content generation, and interactive problem solving across industries including technology, healthcare, and education. The organization offers platforms and APIs that enable enterprises, developers, and researchers to build, test, and deploy intelligent systems, with plug-in extensibility and ongoing model updates to improve performance and safety.

Distyl AI

Series A in 2024
Distyl AI collaborates with organizations worldwide to enhance their artificial intelligence readiness. It develops integrated AI-based solutions tailored to clients' unique data, workflows, and employee requirements, enabling seamless integration with existing technologies.

Inflammatix

Series E in 2024
Inflammatix develops rapid molecular diagnostics tests that interpret the immune system to resolve major clinical challenges. Initially focused on acute bacterial and viral infections, sepsis, and other conditions like tropical infections and autoimmune diseases.

Noetik

Series A in 2024
Noetik is an AI-native biotechnology company focused on the discovery and development of cancer immunotherapies. Utilizing advanced machine learning techniques, Noetik's platform identifies new therapeutic targets and designs innovative treatments. By harnessing self-supervised learning and integrating diverse human multimodal data, the company aims to enhance the precision and effectiveness of immunotherapies. This approach enables the development of more personalized cancer treatments, contributing to the advancement of targeted therapies in oncology.

Speak

Series B in 2024
Speak is an AI-powered language-learning mobile application designed to help users learn English through interactive conversation. The app utilizes advanced speech recognition techniques, allowing users to engage in dialogues about real-world scenarios. This approach enables individuals to improve their English speaking skills by identifying words and phrases, even when spoken with thick accents. Speak's focus on practical conversation enhances the learning experience, making it easier for users to communicate effectively in various contexts.

Waabi

Series B in 2024
Founded in 2021 by Raquel Urtasun, Waabi is a Toronto-based company specializing in autonomous driving technology for the transportation sector. It offers the Waabi Driver, an AI-powered self-driving solution designed for integration with trucks and aimed at safe deployment and large-scale commercialization.

PolyAI

Series C in 2024
PolyAI Ltd is a company that specializes in developing a conversational artificial intelligence platform aimed at enhancing human-machine voice interactions. Established in 2017 and headquartered in London, United Kingdom, with an additional office in New York, the company focuses on building enterprise voice assistants that engage in natural conversations with customers to address their needs. The platform utilizes advanced machine learning and natural language processing technologies, enabling it to understand and respond to customers effectively, regardless of the variations in their speech. Key features of PolyAI’s platform include multilingual support, dynamic flow design, and task-agnostic capabilities, allowing developers to create seamless and human-like interactions within various digital environments.

Cognition

Series A in 2024
Cognition AI is an applied AI lab focused on building end-to-end software agents that act as collaborative AI teammates. Their aim is to support engineering teams in being more efficient and innovative in their projects.

Collaborative Robotics

Series B in 2024
Collaborative Robotics is a team of innovators and builders redefining the future of human-robot interaction. A future in which robots are trustworthy extensions of the environment. They operate, adapt, and react in response.

Symbolica AI

Series A in 2024
Symbolica AI is a research-driven company that develops a unique business model platform. This platform leverages geometric and topological principles in machine learning to train models using formal computational logic, rather than traditional statistical methods. The result is enhanced decision-making capabilities for clients, fostering business growth.

Relation Therapeutics

Seed Round in 2024
Relation Therapeutics is a biotechnology company focused on advancing drug discovery and development. It utilizes human genetics and clinical omics data, alongside patient-derived tissue samples, to identify and validate therapeutic programs. The company employs machine learning to explore the relationships between genes, proteins, and drugs, generating insights that have real translational validity. By combining single-cell multi-omics from patient tissues with functional assays, Relation Therapeutics aims to deepen the understanding of biological processes in human health and disease. This approach enables healthcare providers to discover and develop novel treatments, particularly in areas with unmet medical needs.

Physical Intelligence

Seed Round in 2024
Physical Intelligence is a technology company specializing in integrating artificial intelligence with robotics and physical devices. It develops foundational models and learning algorithms to enable robots and other physical devices to perform a wide range of tasks across various industries.

Limbic

Series A in 2024
Founded in London in 2017, Limbic specializes in developing software solutions for mental health. They create AI-driven agents to assist in patient intake, triage, screening, and therapy, aiming to enhance the efficiency of healthcare providers and improve patient outcomes.

Raspberry AI

Seed Round in 2024
Raspberry AI employs artificial intelligence technology to design styles that are in high demand. The platform offers the convenience of instantly generating technical packs and CADs for any product image, providing a comprehensive solution for product design requirements. It also features automated, high-conversion product descriptions and photography, along with the capability to create new high-fidelity designs from a sketch or reference image.

Recraft

Series A in 2024
Recraft is a creative AI tool.

Sakana AI

Seed Round in 2024
Sakana AI is a research-focused company dedicated to developing innovative foundation models inspired by nature. It specializes in creating an AI model capable of generating text, images, video, code, and multimedia, facilitating collaborative research and development in generative AI. The company's AI development process emphasizes evolution and collective intelligence.

Agrawal's AI initiative

Seed Round in 2024
Agrawal's AI initiative operates as an AI company to create software for LLM developers. Parag Agrawal formerly held the position of Twitter's CEO before Elon Musk's takeover now venturing into artificial intelligence as the venture's name and product details have not been revealed.

Sarvam AI

Series A in 2023
Sarvam AI specializes in developing an artificial intelligence platform tailored to India's diverse linguistic landscape. The platform aims to enhance the robustness, performance, and cost-effectiveness of generative AI app development, deployment, and distribution.

Kognitos

Series A in 2023
Founded in 2021, Kognitos is a San Jose-based company specializing in AI-driven business automation. Its platform leverages natural language processing to automate complex end-to-end processes across departments like finance, HR, and operations with minimal IT involvement.

Black Ore

Seed Round in 2023
Black Ore Technologies, established in 2022 and headquartered in Texas, USA, specializes in AI-driven financial services. The company's core product, Tax Autopilot, is an end-to-end automation solution for 1040 tax preparation, designed to streamline the process for Certified Public Accountants (CPAs) and tax firms. By leveraging artificial intelligence, Black Ore enables professionals to focus on client advisory services and practice growth.

Astrus

Seed Round in 2023
Astrus operates an artificial intelligence-powered platform for automating analog microchip layout design. Its deep reinforcement learning and planning algorithms transform schematics into efficient layouts, accelerating the circuit design process.

Coframe

Seed Round in 2023
Coframe is a technology company that specializes in AI-driven A/B testing and personalization for websites and applications. Its platform continuously analyzes user interactions to optimize content, improving user experience, engagement, and conversion rates. Coframe's unique approach involves training multimodal models to understand user behavior and business goals, enabling user interfaces to autonomously enhance themselves over time.

Vayu Robotics

Seed Round in 2023
Vayu Robotics develops and commercializes advanced robotics technology for automotive sensing, autonomous vehicles, and other applications. The company specializes in creating scalable mobile robotics platforms that incorporate bio-inspired sensing, machine learning, and purposeful robotic design.

Ello

Series A in 2023
Ello develops a reading assistance platform for early literacy that blends real books with artificial intelligence to provide each child with a personalized, phonics-based learning path. The platform delivers interactive digital and physical books, uses speech recognition to offer real-time feedback, and employs motivational strategies to sustain engagement. Grounded in evidence-based reading instruction, Ello supports children when they struggle and helps parents and educators foster confidence, fluency, and a lifelong love of reading.

Automat AI

Seed Round in 2023
Automat offers robotic process automation for Chrome using GPT4 and computer vision. With the aid of its LLM automation tools, Automat streamlines procedures and improves operational efficiency.

Arkifi

Seed Round in 2023
Arkifi is an artificial intelligence company that specializes in creating AI-powered financial analyst tools aimed at enhancing workflow efficiency for financial professionals. By utilizing a novel architectural framework, Arkifi minimizes dependence on traditional generative AI, thereby reducing the risk of factual inaccuracies typically associated with such technologies. This innovative approach allows financial analysts to concentrate on subjective analysis while relying on consistently accurate data, fostering a high level of confidence in the results produced by its tools. Ultimately, Arkifi seeks to empower enterprises with reliable analytics, streamlining their operations and decision-making processes in the financial sector.

Gail

Series B in 2023
GAIL is a technology company specializing in AI-driven conversational automation. It primarily serves insurance agencies and other regulated industries, offering a multilingual AI platform capable of communicating via speech, SMS, email, and WhatsApp. The platform automates sales, support, and customer engagement tasks, providing recordings, transcripts, analytics, and follow-ups, with the aim of reducing costs and improving efficiency. It is known for its easy onboarding and integration processes.

Collaborative Robotics

Series A in 2023
Collaborative Robotics is a team of innovators and builders redefining the future of human-robot interaction. A future in which robots are trustworthy extensions of the environment. They operate, adapt, and react in response.

Speak

Series B in 2023
Speak is an AI-powered language-learning mobile application designed to help users learn English through interactive conversation. The app utilizes advanced speech recognition techniques, allowing users to engage in dialogues about real-world scenarios. This approach enables individuals to improve their English speaking skills by identifying words and phrases, even when spoken with thick accents. Speak's focus on practical conversation enhances the learning experience, making it easier for users to communicate effectively in various contexts.

Univerbal

Seed Round in 2023
Univerbal is a company focused on enhancing language learning through innovative conversational tools. It offers an AI-driven platform that allows learners to engage in unscripted dialogues on a variety of topics, promoting practical speaking fluency from the outset. The technology adapts dynamically to user inputs, providing a personalized learning experience. By analyzing individual progress, Univerbal can deliver tailored feedback and customized suggestions, fostering continuous improvement. The platform also incorporates gamification elements to motivate users and track their development, creating an engaging environment for language practice.

Korbit Technologies

Series A in 2023
Korbit Technologies, founded in 2018 and headquartered in Montreal, Canada, specializes in developing Korbi, an artificial intelligence tutor designed to enhance the learning experience for students globally. The AI-driven platform offers interactive exercises and conversations that adapt to individual learning profiles, delivering personalized pedagogical support such as definitions, explanations, examples, and visual aids. Korbi's features include hands-on exercises, quizzes, visual diagrams, and performance tracking, all aimed at improving learning outcomes and motivation. The company serves a diverse audience, including students, teachers, publishers, and corporations, and has successfully trained nearly 20,000 learners in data science and AI. Korbit Technologies is committed to democratizing education by providing high-quality, personalized learning experiences at an accessible cost, and it has gained recognition as one of the top AI startups globally, receiving positive media coverage from prominent publications.

Kind Humanoid

Pre Seed Round in 2023
Kind Humanoid develops intelligent humanoid robots powered by AI and large language models. These robots assist humans in various tasks, helping businesses optimize operations and automate processes.

Fulfil Solutions

Series B in 2023
Fulfil Solutions is a developer of advanced robotic automation technology aimed at transforming the online grocery sector. The company specializes in creating a fully automated fulfillment system designed to enhance profitability while addressing food supply chain challenges. By integrating mechanical design, software, robotics, computer vision, and deep learning, Fulfil Solutions offers solutions that streamline picking, packing, and inventory control across various product categories and temperature zones. Their innovative technology seeks to reduce waste, minimize environmental impact, and lower emissions, enabling companies to automate their supply chain processes effectively within a compact operational footprint. Through these advancements, Fulfil Solutions supports sustainable and customer-centric online grocery operations at scale.

Astrus

Pre Seed Round in 2023
Astrus operates an artificial intelligence-powered platform for automating analog microchip layout design. Its deep reinforcement learning and planning algorithms transform schematics into efficient layouts, accelerating the circuit design process.

Regie.ai

Series A in 2023
Regie.ai is a technology company that specializes in AI-powered sales engagement platforms. Its flagship product, RegieOne, automates outbound prospecting tasks, enhancing workflow efficiency for operations teams. The platform integrates sales engagement, parallel dialing, data enrichment, and intent data analysis, providing users with a centralized view of their processes. Additionally, Regie.ai offers an AI content platform that creates, tests, and analyzes personalized prospecting sales campaigns, aiming to boost engagement and optimize front-line performance.

PolyAI

Series B in 2022
PolyAI Ltd is a company that specializes in developing a conversational artificial intelligence platform aimed at enhancing human-machine voice interactions. Established in 2017 and headquartered in London, United Kingdom, with an additional office in New York, the company focuses on building enterprise voice assistants that engage in natural conversations with customers to address their needs. The platform utilizes advanced machine learning and natural language processing technologies, enabling it to understand and respond to customers effectively, regardless of the variations in their speech. Key features of PolyAI’s platform include multilingual support, dynamic flow design, and task-agnostic capabilities, allowing developers to create seamless and human-like interactions within various digital environments.

Arpeggio Bio

Series A in 2022
Arpeggio Bio, established in 2017 and headquartered in Boulder, Colorado, specializes in developing innovative software that captures snapshots of cellular RNA activity. By combining biological assays with advanced machine learning algorithms, the company enables pharmaceutical and biotechnology firms to understand a drug's mechanism of action at low sequencing depths. Arpeggio Bio's technology reveals intricate biological networks, facilitating more informed therapeutic development.

Collaborative Robotics

Seed Round in 2022
Collaborative Robotics is a team of innovators and builders redefining the future of human-robot interaction. A future in which robots are trustworthy extensions of the environment. They operate, adapt, and react in response.

CHARM Therapeutics

Series A in 2022
CHARM Therapeutics uses 3D deep learning and advanced drug discovery technologies to develop transformational medicines for diseases that are difficult to treat, aiming to enable clinicians to target undruggable disease targets with novel therapies that offer potentially life-changing efficacy.

Relation Therapeutics

Seed Round in 2022
Relation Therapeutics is a biotechnology company focused on advancing drug discovery and development. It utilizes human genetics and clinical omics data, alongside patient-derived tissue samples, to identify and validate therapeutic programs. The company employs machine learning to explore the relationships between genes, proteins, and drugs, generating insights that have real translational validity. By combining single-cell multi-omics from patient tissues with functional assays, Relation Therapeutics aims to deepen the understanding of biological processes in human health and disease. This approach enables healthcare providers to discover and develop novel treatments, particularly in areas with unmet medical needs.

Anagenex

Series A in 2022
Anagenex is a biotechnology company developing a novel platform for drug discovery. This platform focuses on challenging targets by combining machine learning with DNA-encoded libraries and proprietary AI models to accelerate small molecule drug discovery.

Finnt

Seed Round in 2022
Finnt is a developer of automated financial analysis software designed to enhance the efficiency of corporate finance operations. The company leverages artificial intelligence to improve analytical capabilities and streamline workflows for financial teams. By removing manual and repetitive tasks, Finnt's software accelerates decision-making processes for financial firms. Additionally, it enables users to establish shared savings goals and track spending habits, facilitating effective savings for family members both domestically and internationally. Through its innovative approach, Finnt aims to help finance professionals focus on strategic initiatives rather than tedious administrative functions.

Nomagic

Series A in 2022
Nomagic, Inc. is a technology company based in Warsaw, Poland, specializing in robotic manipulation solutions for order fulfillment in e-commerce. The company develops smart pick-and-place robotic systems that enhance efficiency, flexibility, and reliability in warehouses. By automating tedious tasks, Nomagic's solutions help reduce fulfillment costs and address labor shortages, allowing operations to scale effectively and operate around the clock. Powered by artificial intelligence, their robotic systems continuously learn and adapt to changing conditions, enabling warehouse operators to improve agility and ensure reliable delivery of goods. Nomagic's technology has been implemented in notable locations, including packing lines at Cdiscount, a leading French eCommerce platform.

Myko

Seed Round in 2022
Myko AI is an artificial intelligence tool that pulls financial data from spreadsheets and helps make successful revenue-generating decisions with minimum onboarding. The company's application integrates directly into users' existing CRM platforms and chat applications, allowing data to be analyzed in seconds. This enables businesses to drive more revenue by providing their teams with deeper analytical capabilities and improving the financial reporting process by spending less time copying and pasting data.

Anagenex

Seed Round in 2022
Anagenex is a biotechnology company developing a novel platform for drug discovery. This platform focuses on challenging targets by combining machine learning with DNA-encoded libraries and proprietary AI models to accelerate small molecule drug discovery.

Fundbox

Series D in 2021
Founded in 2013, Fundbox operates a payments network that facilitates transactions between businesses. It provides credit and payment solutions to small businesses serving other businesses (SMB2B), empowering them with fast and intuitive access to business credit.

Mimica Automation

Series A in 2021
Mimica Automation Limited is a London-based company established in 2018 that specializes in developing software to automate repetitive tasks through machine learning. The company's primary product observes users over a period of 2-3 weeks, capturing their clicks and keystrokes to understand their workflow. This data is then processed using advanced algorithms to create a comprehensive automation map, streamlining the user's tasks. Mimica's technology aims to enhance productivity by simplifying the automation process, allowing businesses to focus on more strategic activities.

PolyAI

Series A in 2021
PolyAI Ltd is a company that specializes in developing a conversational artificial intelligence platform aimed at enhancing human-machine voice interactions. Established in 2017 and headquartered in London, United Kingdom, with an additional office in New York, the company focuses on building enterprise voice assistants that engage in natural conversations with customers to address their needs. The platform utilizes advanced machine learning and natural language processing technologies, enabling it to understand and respond to customers effectively, regardless of the variations in their speech. Key features of PolyAI’s platform include multilingual support, dynamic flow design, and task-agnostic capabilities, allowing developers to create seamless and human-like interactions within various digital environments.

Known Medicine

Seed Round in 2021
Known Medicine Inc. is a biotechnology company based in Salt Lake City, Utah, founded in 2020. The company specializes in developing a custom organoid platform designed for tumor sensitivity testing through advanced bioengineering techniques. Known Medicine focuses on transforming the process of evaluating how tumors respond to cancer therapies by taking tumor samples and breaking them down into microtumors. These microtumors are treated in specialized micro-environments using various methods to ascertain the most effective treatment options. The company's platform integrates machine learning with omics data to identify predictive biomarkers that inform oncologists about cancer cell behavior and potential treatment pathways, ultimately aiming to enhance personalized cancer care.

Deep Genomics

Series C in 2021
Deep Genomics is a Toronto-based company founded in 2014. It specializes in developing individualized genetic medicines using artificial intelligence systems to accelerate drug discovery and development processes, including target discovery, lead optimization, toxicity assessment, and innovative trial design. The company focuses on therapies for rare metabolic, ophthalmologic, and neurodegenerative disorders, utilizing oligonucleotide therapies that target genetic determinants of disease at the RNA or DNA level.

Berkshire Grey

Post in 2021
Berkshire Grey, Inc. is a technology company specializing in the development of artificial intelligence-driven robotic and automated material handling systems. Founded in 2013 and based in Lexington, Massachusetts, the company focuses on automating tasks traditionally performed by humans in commercial settings, enhancing efficiency in fulfillment, supply chain, and logistics operations. Its offerings include a range of robotic solutions, such as autonomous picking and sorting systems, mobile robotic units, and dynamic parcel sortation technologies. Additionally, Berkshire Grey provides electromechanical solutions that incorporate vision systems and advanced scanning technologies. By leveraging AI, computer vision, and machine learning, the company's systems enable clients to achieve higher accuracy and throughput speeds while managing diverse product assortments. The majority of its revenue is generated from North America, positioning Berkshire Grey as a significant player in the automation landscape.

Gail

Series A in 2021
GAIL is a technology company specializing in AI-driven conversational automation. It primarily serves insurance agencies and other regulated industries, offering a multilingual AI platform capable of communicating via speech, SMS, email, and WhatsApp. The platform automates sales, support, and customer engagement tasks, providing recordings, transcripts, analytics, and follow-ups, with the aim of reducing costs and improving efficiency. It is known for its easy onboarding and integration processes.

Waabi

Series A in 2021
Founded in 2021 by Raquel Urtasun, Waabi is a Toronto-based company specializing in autonomous driving technology for the transportation sector. It offers the Waabi Driver, an AI-powered self-driving solution designed for integration with trucks and aimed at safe deployment and large-scale commercialization.

Inflammatix

Series D in 2021
Inflammatix develops rapid molecular diagnostics tests that interpret the immune system to resolve major clinical challenges. Initially focused on acute bacterial and viral infections, sepsis, and other conditions like tropical infections and autoimmune diseases.

Lumiata

Series B in 2021
Lumiata is a predictive health analytics company that applies artificial intelligence to healthcare data to deliver real-time, patient-level predictions. It builds a medical graph to organize symptoms, diagnoses, procedures and medications, enabling risk-bearing organizations such as payers, hospital networks, and population health programs to forecast health trajectories, cost, and care needs. The Lumiata Risk Matrix provides time-based predictions with explanations of medical reasoning. The platform combines big data, clinical knowledge, and proprietary intellectual property drawn from over 120 million patient records to support use cases like underwriting and care management. Founded in 2013 and based in San Mateo, California, Lumiata serves providers, payers, and digital health companies, enabling predictive analytics at scale while protecting privacy.

Curai Health

Series B in 2020
Curai Health is a virtual care company founded in 2017 by Neal Khosla and Xavier Amatriain, headquartered in Palo Alto. The company specializes in providing affordable primary care through a chat-based interface that integrates artificial intelligence with human clinicians. This approach leverages advanced machine learning tools to streamline patient interactions and enhance diagnostic accuracy. By creating a responsive learning healthcare system, Curai Health aims to make high-quality primary care accessible to everyone, reducing the overall cost of care delivery. The service is available directly to consumers and can also be accessed through enterprise partnerships, emphasizing its commitment to improving healthcare accessibility and affordability.

WaveOne

Series A in 2020
WaveOne, Inc. is a technology company based in Palo Alto, California, that specializes in developing advanced video and image compression software. Founded in 2016, the company leverages machine learning and artificial intelligence to create custom-tailored, context-dependent solutions for digital media compression. WaveOne's technology utilizes a codec that operates significantly faster than traditional methods, enabling the processing of images at high speeds while maintaining clarity. This innovation allows digital media industries to efficiently process, print, upload, and share high-quality images, positioning WaveOne at the forefront of digital media technology.

Menten AI

Seed Round in 2020
Menten AI, established in 2018 with headquarters in San Francisco and a satellite office in Toronto, is an early-stage biotech company specializing in drug discovery. It leverages machine learning and quantum computing to develop novel protein-based drugs and enzymes for pharmaceutical and chemical industries. Menten AI's core offering is a proprietary protein design algorithm tailored for current and near-term quantum computers, enabling efficient exploration of protein structures for therapeutic applications, such as oncology and neurodegeneration, and industrial enzyme development.

HeartVista

Series A in 2020
HeartVista is a medical technology company that provides one-click diagnostic imaging. It brought in machine learning to make the scanning process faster, easier, and more consistent. Its platform leverages existing scanners and contains all of the mri tools needed for a comprehensive cardiac examination, with just one click.

Ello

Seed Round in 2020
Ello develops a reading assistance platform for early literacy that blends real books with artificial intelligence to provide each child with a personalized, phonics-based learning path. The platform delivers interactive digital and physical books, uses speech recognition to offer real-time feedback, and employs motivational strategies to sustain engagement. Grounded in evidence-based reading instruction, Ello supports children when they struggle and helps parents and educators foster confidence, fluency, and a lifelong love of reading.

Rosebud AI

Seed Round in 2020
Rosebud AI develops software that enables users to create digital avatars for various purposes. The platform allows filtering by demographic, age, and style. Based in San Francisco, the company aims to make visual content creation accessible through AI-generated game assets.

iMerit

Series B in 2020
iMerit is a prominent AI data solutions provider focused on delivering high-quality data for machine learning and artificial intelligence applications. The company specializes in data labeling technologies and services across various industries, including agricultural AI, autonomous vehicles, commerce, geospatial, government, financial services, and medical AI. Headquartered in San Jose, California, iMerit operates large teams dedicated to computer vision and natural language processing in India, the United States, Bhutan, and Europe. Founded by Radha Basu, iMerit employs over 5,000 full-time staff, with more than half being women, reflecting its commitment to diversity. The company serves numerous Fortune 500 clients, helping them achieve optimal results from their algorithms through enriched and accurately labeled data.

Nomagic

Seed Round in 2020
Nomagic, Inc. is a technology company based in Warsaw, Poland, specializing in robotic manipulation solutions for order fulfillment in e-commerce. The company develops smart pick-and-place robotic systems that enhance efficiency, flexibility, and reliability in warehouses. By automating tedious tasks, Nomagic's solutions help reduce fulfillment costs and address labor shortages, allowing operations to scale effectively and operate around the clock. Powered by artificial intelligence, their robotic systems continuously learn and adapt to changing conditions, enabling warehouse operators to improve agility and ensure reliable delivery of goods. Nomagic's technology has been implemented in notable locations, including packing lines at Cdiscount, a leading French eCommerce platform.

Berkshire Grey

Series B in 2020
Berkshire Grey, Inc. is a technology company specializing in the development of artificial intelligence-driven robotic and automated material handling systems. Founded in 2013 and based in Lexington, Massachusetts, the company focuses on automating tasks traditionally performed by humans in commercial settings, enhancing efficiency in fulfillment, supply chain, and logistics operations. Its offerings include a range of robotic solutions, such as autonomous picking and sorting systems, mobile robotic units, and dynamic parcel sortation technologies. Additionally, Berkshire Grey provides electromechanical solutions that incorporate vision systems and advanced scanning technologies. By leveraging AI, computer vision, and machine learning, the company's systems enable clients to achieve higher accuracy and throughput speeds while managing diverse product assortments. The majority of its revenue is generated from North America, positioning Berkshire Grey as a significant player in the automation landscape.

Arpeggio Bio

Seed Round in 2020
Arpeggio Bio, established in 2017 and headquartered in Boulder, Colorado, specializes in developing innovative software that captures snapshots of cellular RNA activity. By combining biological assays with advanced machine learning algorithms, the company enables pharmaceutical and biotechnology firms to understand a drug's mechanism of action at low sequencing depths. Arpeggio Bio's technology reveals intricate biological networks, facilitating more informed therapeutic development.

Inflammatix

Series C in 2020
Inflammatix develops rapid molecular diagnostics tests that interpret the immune system to resolve major clinical challenges. Initially focused on acute bacterial and viral infections, sepsis, and other conditions like tropical infections and autoimmune diseases.

Deep Genomics

Series B in 2020
Deep Genomics is a Toronto-based company founded in 2014. It specializes in developing individualized genetic medicines using artificial intelligence systems to accelerate drug discovery and development processes, including target discovery, lead optimization, toxicity assessment, and innovative trial design. The company focuses on therapies for rare metabolic, ophthalmologic, and neurodegenerative disorders, utilizing oligonucleotide therapies that target genetic determinants of disease at the RNA or DNA level.

Ghost Autonomy

Series C in 2019
Ghost Autonomy is a technology company focused on making self-driving accessible to the consumer market. It develops an advanced autonomous driving software platform designed for automakers, leveraging innovative artificial intelligence breakthroughs to ensure safe and scalable highway autonomy. The company's platform includes AI-enabled software that encompasses perception systems, planning and decision-making algorithms, and vehicle control software. This comprehensive approach allows automakers and suppliers to integrate autonomous driving capabilities into their vehicles with minimal hardware modifications, facilitating a more affordable and efficient transition to self-driving technology.

Korbit Technologies

Seed Round in 2019
Korbit Technologies, founded in 2018 and headquartered in Montreal, Canada, specializes in developing Korbi, an artificial intelligence tutor designed to enhance the learning experience for students globally. The AI-driven platform offers interactive exercises and conversations that adapt to individual learning profiles, delivering personalized pedagogical support such as definitions, explanations, examples, and visual aids. Korbi's features include hands-on exercises, quizzes, visual diagrams, and performance tracking, all aimed at improving learning outcomes and motivation. The company serves a diverse audience, including students, teachers, publishers, and corporations, and has successfully trained nearly 20,000 learners in data science and AI. Korbit Technologies is committed to democratizing education by providing high-quality, personalized learning experiences at an accessible cost, and it has gained recognition as one of the top AI startups globally, receiving positive media coverage from prominent publications.

Fundbox

Series C in 2019
Founded in 2013, Fundbox operates a payments network that facilitates transactions between businesses. It provides credit and payment solutions to small businesses serving other businesses (SMB2B), empowering them with fast and intuitive access to business credit.

OpenAI

Corporate Round in 2019
OpenAI is an AI research and deployment company that develops general-purpose artificial intelligence technologies and applies them to real-world problems. It conducts machine learning research and builds systems such as large-scale language models, multimodal input handling, and code generation to support automation, data analysis, content generation, and interactive problem solving across industries including technology, healthcare, and education. The organization offers platforms and APIs that enable enterprises, developers, and researchers to build, test, and deploy intelligent systems, with plug-in extensibility and ongoing model updates to improve performance and safety.

Abacus.AI

Seed Round in 2019
Abacus.AI offers cloud artificial intelligence services, helping businesses integrate deep learning models into operations and customer experiences. Established in 2019, the company is headquartered in San Francisco.

OpenAI

Venture Round in 2019
OpenAI is an AI research and deployment company that develops general-purpose artificial intelligence technologies and applies them to real-world problems. It conducts machine learning research and builds systems such as large-scale language models, multimodal input handling, and code generation to support automation, data analysis, content generation, and interactive problem solving across industries including technology, healthcare, and education. The organization offers platforms and APIs that enable enterprises, developers, and researchers to build, test, and deploy intelligent systems, with plug-in extensibility and ongoing model updates to improve performance and safety.

Datera

Series C in 2018
Datera is a developer of a data management platform aimed at simplifying enterprise data storage. The company's innovative platform utilizes intelligent placement technology and applies machine learning to automate data orchestration and management. This enables organizations to efficiently handle data capacity and performance based on specific application requirements. Founded by experts in the Linux I/O storage stack, Datera partners with leading server-based infrastructure companies such as HPE, Intel, and Cisco, delivering solutions that achieve a total cost of ownership and operation that is significantly lower than traditional methods.

Pymetrics

Series B in 2018
Pymetrics, Inc. is a company that specializes in neuroscience-based assessment and prediction technology aimed at transforming hiring, retention, and employee development processes. Founded in 2013 and headquartered in New York City, Pymetrics offers solutions that combine cognitive and emotional assessments with a dynamic recommendation engine. This platform utilizes artificial intelligence and machine learning to analyze behavioral data collected from successful professionals across various roles, helping organizations identify key traits that differentiate high performers from the general population. By focusing on improving the recruitment process, Pymetrics aims to enhance accuracy and reduce bias in hiring decisions.

Remedy

Seed Round in 2018
Remedy is a prescriptive chronic care analytics platform employing artificial intelligence to help value-based health systems determine who should get what care, when, how, and by whom to maximize patient health outcomes per dollar spent. We are a design-driven company with core medical AI technology capable of diagnosing disease, catching hidden high-risk diagnoses, and projecting the development of patient’s health into the future. Built around our core AI engine, our first product Remedy Sentinel helps value-based providers identify hidden chronic, co-morbid conditions and intervene by engaging high-risk patients prior to onset. We envision a world where healthcare marries the science of “health” with the art of “care”: scientific, data-driven decision making drives the best outcomes for each individual patient, and frees providers to focus on applying their human touch. Remedy combines novel artificial intelligence algorithms for predictive medical analytics with a healthcare-optimized product development process to give leaders the tools they need to transform their delivery networks and thrive in a value-based care environment. With this approach, Remedy builds a scalable suite of products that, when deployed, learn from experience, and grow into a solution optimized to fit the needs of specific provider groups and the populations they serve. Remedy systematically maximizes the patient health outcome achieved with each dollar spent by using AI to help determine what care is delivered to whom, when it is delivered, where it is delivered, how it is delivered, followed, and supported, and who should deliver it. We not only surface insights, but also build the necessary tools and helps coordinate step-by-step implementation processes to affect real change.

Ghost Autonomy

Series B in 2018
Ghost Autonomy is a technology company focused on making self-driving accessible to the consumer market. It develops an advanced autonomous driving software platform designed for automakers, leveraging innovative artificial intelligence breakthroughs to ensure safe and scalable highway autonomy. The company's platform includes AI-enabled software that encompasses perception systems, planning and decision-making algorithms, and vehicle control software. This comprehensive approach allows automakers and suppliers to integrate autonomous driving capabilities into their vehicles with minimal hardware modifications, facilitating a more affordable and efficient transition to self-driving technology.

Lumiata

Series B in 2018
Lumiata is a predictive health analytics company that applies artificial intelligence to healthcare data to deliver real-time, patient-level predictions. It builds a medical graph to organize symptoms, diagnoses, procedures and medications, enabling risk-bearing organizations such as payers, hospital networks, and population health programs to forecast health trajectories, cost, and care needs. The Lumiata Risk Matrix provides time-based predictions with explanations of medical reasoning. The platform combines big data, clinical knowledge, and proprietary intellectual property drawn from over 120 million patient records to support use cases like underwriting and care management. Founded in 2013 and based in San Mateo, California, Lumiata serves providers, payers, and digital health companies, enabling predictive analytics at scale while protecting privacy.

Zebra Medical Vision

Series C in 2018
Zebra Medical Vision is an Israel-based company that develops an imaging analytics platform for healthcare. The platform supplies clinicians with imaging research tools, provides advanced learning and computer-vision diagnostic algorithms for developers, and offers risk management and preventative care tools for providers. The company also offers researchers access to tools and datasets to accelerate the development of decision-support and diagnostic technologies. Founded in 2014 and headquartered in Shefayim, Zebra Medical Vision collaborates with partners such as USARAD Holdings and TELUS Ventures and has deployed its AI-enabled imaging analytics across hospitals worldwide.

Giant.AI

Seed Round in 2018
Founded in San Francisco in 2017, Giant.AI specializes in developing intelligent robotic workers using advanced computer vision and deep learning technologies. These robots are designed to collaborate with human workers in various low-skill manual labor industries such as manufacturing, agriculture, and logistics, aiming to enhance productivity and improve working conditions.

Curai Health

Series A in 2018
Curai Health is a virtual care company founded in 2017 by Neal Khosla and Xavier Amatriain, headquartered in Palo Alto. The company specializes in providing affordable primary care through a chat-based interface that integrates artificial intelligence with human clinicians. This approach leverages advanced machine learning tools to streamline patient interactions and enhance diagnostic accuracy. By creating a responsive learning healthcare system, Curai Health aims to make high-quality primary care accessible to everyone, reducing the overall cost of care delivery. The service is available directly to consumers and can also be accessed through enterprise partnerships, emphasizing its commitment to improving healthcare accessibility and affordability.

Sagence AI

Series A in 2018
Analog Inference is a company focused on advancing neural computing through innovative technology. Founded by experienced professionals from the computing industry and supported by Khosla Ventures, the company is developing its first generation of products. It specializes in deep sub-threshold analog in-memory computation, which allows for the execution of complex neural networks at full resolution while maintaining low latency and eliminating the need for active cooling. This technology enables the performance of data-center-grade artificial intelligence workloads with significantly reduced power consumption, facilitating the deployment of server-class networks in more cost-effective devices.

Atomwise

Series A in 2018
Atomwise, Inc. is a biotechnology company specializing in deep learning artificial intelligence technology for small molecule drug discovery. Based in San Francisco and founded in 2012, the company has developed AtomNet, a pioneering AI platform that facilitates virtual screening of molecules by predicting the binding of small molecules to proteins through a statistical analysis of experimental affinity measurements and protein structures. Atomwise is focused on addressing over 600 unique disease targets and has established collaborations with over 250 partners, including prominent pharmaceutical and biotechnology firms. By leveraging its advanced technology, Atomwise aims to revolutionize the drug discovery process and advance a pipeline of small-molecule drug candidates into preclinical studies. The company was previously known as Chematria, Inc. and rebranded to Atomwise, Inc. in 2015.

Bidgely

Series C in 2018
Bidgely is a technology company that provides disaggregation-powered utility analytics and customer engagement solutions. Its cloud-based HomeBeat platform disaggregates household energy consumption to the appliance level, enabling utilities to understand usage patterns and tailor energy programs. The UtilityAI Platform delivers customer energy insights based on actual energy habits, supporting energy efficiency initiatives and consumer engagement for utilities serving residential customers worldwide. Bidgely uses machine learning to monitor energy data and identify appliance-level usage, helping utilities manage peak demand and reimagine customer engagement. The company serves utilities globally and is headquartered in Mountain View, California, with an office in Bengaluru, India.

DiscernDx

Seed Round in 2018
DiscernDx is a healthcare technology company based in Palo Alto, California, founded in 2017. It operates an online platform that provides users with access to individualized clinical and molecular data, enabling proactive health management and informed decision-making. The platform leverages artificial intelligence and machine learning to detect, measure, and interpret signals from the body, facilitating early disease detection and personalized care. By focusing on the earliest indicators of developing diseases as well as existing conditions, DiscernDx aims to improve health outcomes and transform the healthcare experience for individuals.

Olive

Series C in 2017
Olive AI, Inc. specializes in developing artificial intelligence and robotic process automation solutions tailored for healthcare organizations. Founded in 2012 and based in Columbus, Ohio, the company offers an AI-as-a-Service platform that automates a variety of administrative workflows, including claim status checks, account updates, and prior authorizations. By streamlining these repetitive and high-volume tasks, Olive allows healthcare professionals to focus on more creative and empathetic aspects of patient care. The software acts as an intermediary between different systems and data, helping to reduce administrative errors and improve cash collections, ultimately enhancing overall efficiency and patient outcomes in the healthcare sector. Olive AI, Inc. was previously known as CrossChx, Inc. before rebranding in July 2018.

Luka

Series A in 2017
Luka is a San Francisco-based software development company that developed Replika, an AI-powered personal chatbot platform. The company builds AI chatbots for text-based conversations that recognize user tone and personality, store memories, and learn to imitate a user's texting style, effectively functioning as a conversational journal. Replika originated as a personal AI that users teach through text conversations, and is powered by a proprietary deep learning architecture. The platform aims to provide a personalized digital companion and conversational assistant.

Lumiata

Series A in 2017
Lumiata is a predictive health analytics company that applies artificial intelligence to healthcare data to deliver real-time, patient-level predictions. It builds a medical graph to organize symptoms, diagnoses, procedures and medications, enabling risk-bearing organizations such as payers, hospital networks, and population health programs to forecast health trajectories, cost, and care needs. The Lumiata Risk Matrix provides time-based predictions with explanations of medical reasoning. The platform combines big data, clinical knowledge, and proprietary intellectual property drawn from over 120 million patient records to support use cases like underwriting and care management. Founded in 2013 and based in San Mateo, California, Lumiata serves providers, payers, and digital health companies, enabling predictive analytics at scale while protecting privacy.

Deep Genomics

Series A in 2017
Deep Genomics is a Toronto-based company founded in 2014. It specializes in developing individualized genetic medicines using artificial intelligence systems to accelerate drug discovery and development processes, including target discovery, lead optimization, toxicity assessment, and innovative trial design. The company focuses on therapies for rare metabolic, ophthalmologic, and neurodegenerative disorders, utilizing oligonucleotide therapies that target genetic determinants of disease at the RNA or DNA level.

Pymetrics

Series A in 2017
Pymetrics, Inc. is a company that specializes in neuroscience-based assessment and prediction technology aimed at transforming hiring, retention, and employee development processes. Founded in 2013 and headquartered in New York City, Pymetrics offers solutions that combine cognitive and emotional assessments with a dynamic recommendation engine. This platform utilizes artificial intelligence and machine learning to analyze behavioral data collected from successful professionals across various roles, helping organizations identify key traits that differentiate high performers from the general population. By focusing on improving the recruitment process, Pymetrics aims to enhance accuracy and reduce bias in hiring decisions.

Paravision

Series B in 2017
Founded in 2013 and based in San Francisco, Paravision specializes in developing advanced face recognition software. Trusted globally by security device manufacturers, solution providers, systems integrators, and financial services firms, their industry-leading Vision AI software delivers frictionless experiences and comprehensive safety through modular, scalable toolsets.

Vicarious

Series C in 2017
Vicarious is an artificial intelligence company that utilizes the principles of neuro and cognitive science to create general intelligence for robots. Founded in 2010 by Dr. Dileep George and D. Scott Phoenix, Vicarious develops technology that mimics the functions of the human brain, aiming to achieve human-level intelligence in areas such as vision, language, and motor control. The company's algorithmic architecture focuses on visual perception challenges, including recognition, segmentation, and scene parsing. This innovative approach enables robot manufacturers to design robots that exhibit advanced intelligence and enhanced task efficiency, positioning Vicarious as a leader in the advancement of intelligent robotic systems.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.